AU2002367431A1 - Drugs against obeisty and drugs against fatty liver - Google Patents
Drugs against obeisty and drugs against fatty liverInfo
- Publication number
- AU2002367431A1 AU2002367431A1 AU2002367431A AU2002367431A AU2002367431A1 AU 2002367431 A1 AU2002367431 A1 AU 2002367431A1 AU 2002367431 A AU2002367431 A AU 2002367431A AU 2002367431 A AU2002367431 A AU 2002367431A AU 2002367431 A1 AU2002367431 A1 AU 2002367431A1
- Authority
- AU
- Australia
- Prior art keywords
- drugs against
- obeisty
- fatty liver
- drugs
- against fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-401413 | 2001-12-28 | ||
JP2001401413A JP2005194191A (en) | 2001-12-28 | 2001-12-28 | Drug against obesity and therapeutic drug for fatty liver |
PCT/JP2002/013669 WO2003057255A1 (en) | 2001-12-28 | 2002-12-26 | Drugs against obeisty and drugs against fatty liver |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002367431A1 true AU2002367431A1 (en) | 2003-07-24 |
Family
ID=19189772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002367431A Abandoned AU2002367431A1 (en) | 2001-12-28 | 2002-12-26 | Drugs against obeisty and drugs against fatty liver |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2005194191A (en) |
AU (1) | AU2002367431A1 (en) |
WO (1) | WO2003057255A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2305352A1 (en) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders |
EP2351743A4 (en) * | 2008-10-27 | 2012-05-09 | Takeda Pharmaceutical | Bicyclic compound |
WO2012108478A1 (en) * | 2011-02-09 | 2012-08-16 | 武田薬品工業株式会社 | Monocyclic compound |
AU2014236719B2 (en) * | 2013-03-15 | 2018-06-21 | The California Institute For Biomedical Research | Compounds and methods for inducing chondrogenesis |
EP3043800A1 (en) | 2013-09-12 | 2016-07-20 | Pfizer Inc. | Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59164716A (en) * | 1983-03-09 | 1984-09-17 | Mitsubishi Chem Ind Ltd | Biosynthetic inhibitor for fatty acid |
JPH11171856A (en) * | 1997-09-26 | 1999-06-29 | Fujirebio Inc | Acylsulfonamide derivative |
AU2001267878A1 (en) * | 2000-07-05 | 2002-01-14 | Ajinomoto Co. Inc. | Hypoglycemics |
EP1316548A4 (en) * | 2000-07-05 | 2004-05-19 | Ajinomoto Kk | Acylsulfonamide derivatives |
-
2001
- 2001-12-28 JP JP2001401413A patent/JP2005194191A/en active Pending
-
2002
- 2002-12-26 AU AU2002367431A patent/AU2002367431A1/en not_active Abandoned
- 2002-12-26 WO PCT/JP2002/013669 patent/WO2003057255A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2005194191A (en) | 2005-07-21 |
WO2003057255A1 (en) | 2003-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002357119A1 (en) | Mitocidal compositions and methods | |
AU2001294808A1 (en) | Catecholamine pharmaceutical compositions and methods | |
AU2002306269A1 (en) | N-arylphenylacetamide derivatives and pharmaceutical composition containing the same | |
AU2002305523A1 (en) | Dioxanes and uses thereof | |
AU2002351764A1 (en) | Flavonoid compounds and their pharmaceutical uses | |
AU2003296369A1 (en) | Imminoamines and preparation thereof | |
AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
AU4834200A (en) | Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
AU2002359694A1 (en) | Compounds and methods | |
AU2001227084A1 (en) | N-arylhydrazide compounds and use thereof as drugs | |
AU2002367431A1 (en) | Drugs against obeisty and drugs against fatty liver | |
AU2002338989A1 (en) | Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives | |
AU4543500A (en) | Pharmaceutical compositions and uses | |
AUPR548601A0 (en) | Pyrazolopyrazinecompound and pharmaceutical use thereof | |
AU5979300A (en) | Angiopoietin-6 and uses thereof | |
AU2002349129A1 (en) | Lipid structures and uses thereof | |
AU5893001A (en) | Top support assembly and support member | |
AU2002307237A1 (en) | Carboxybenzopyran derivatives and compositions | |
AU2002311196B2 (en) | Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents | |
AU2002313180A1 (en) | Lipid lowering composition comprising carnitine and phytosterol | |
AU2002305940A1 (en) | Neuroprotectants formulations and methods | |
AU2002247222A1 (en) | (z)-styrylbenzylsulfones and pharmaceutical uses thereof | |
AU2002245959A1 (en) | An antioxidant composition and a cosmetic or pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |